[go: up one dir, main page]

SE8103071L - Antitumorkompositioner samt sett att framstella dessa - Google Patents

Antitumorkompositioner samt sett att framstella dessa

Info

Publication number
SE8103071L
SE8103071L SE8103071A SE8103071A SE8103071L SE 8103071 L SE8103071 L SE 8103071L SE 8103071 A SE8103071 A SE 8103071A SE 8103071 A SE8103071 A SE 8103071A SE 8103071 L SE8103071 L SE 8103071L
Authority
SE
Sweden
Prior art keywords
way
make
amsa
compositions
antitumor compositions
Prior art date
Application number
SE8103071A
Other languages
Unknown language ( )
English (en)
Other versions
SE460457B (sv
Inventor
M A Kaplan
D Bouzard
C Perol
J Stemer
A Weber
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8103071L publication Critical patent/SE8103071L/sv
Publication of SE460457B publication Critical patent/SE460457B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8103071A 1980-05-16 1981-05-15 Stabil, fast och vattenloeslig farmaceutisk komposition innehaallande 4'-(9-akridinylamino)-metansulfon-m-anisidid (m-amsa) SE460457B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/147,056 US4360523A (en) 1980-05-16 1980-05-16 Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide

Publications (2)

Publication Number Publication Date
SE8103071L true SE8103071L (sv) 1981-11-17
SE460457B SE460457B (sv) 1989-10-16

Family

ID=22520148

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8103071A SE460457B (sv) 1980-05-16 1981-05-15 Stabil, fast och vattenloeslig farmaceutisk komposition innehaallande 4'-(9-akridinylamino)-metansulfon-m-anisidid (m-amsa)

Country Status (21)

Country Link
US (1) US4360523A (sv)
JP (1) JPS579716A (sv)
AT (1) AT374682B (sv)
AU (1) AU543726B2 (sv)
BE (1) BE888832A (sv)
CA (1) CA1160571A (sv)
CH (1) CH647677A5 (sv)
DE (1) DE3119510A1 (sv)
DK (1) DK159376C (sv)
FI (1) FI70793C (sv)
FR (1) FR2482458A1 (sv)
GB (1) GB2076288B (sv)
GR (1) GR75658B (sv)
IE (1) IE51285B1 (sv)
IT (1) IT1170970B (sv)
LU (1) LU83363A1 (sv)
NL (1) NL8102362A (sv)
NZ (1) NZ196985A (sv)
SE (1) SE460457B (sv)
YU (1) YU44831B (sv)
ZA (1) ZA813188B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
US4626541A (en) * 1985-09-12 1986-12-02 Bristol-Myers Company Water soluble salt composition of m-AMSA
DE3819842C1 (sv) * 1988-03-23 1989-12-21 Karl Heinz Dr. 7100 Heilbronn De Thiel
DE3809814C1 (en) * 1988-03-23 1989-09-07 Karl Heinz Dr.Med. 7100 Heilbronn De Thiel Use of aminoacridines for iontophoretic treatment of bladder cancer
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
DE102004031538A1 (de) * 2004-06-29 2006-02-09 Baxter International Inc., Deerfield Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
WO2006002887A1 (en) * 2004-06-29 2006-01-12 Baxter International Inc. Aqueous drink solution of indibulin (d-24851) and an organic acid
EP1809279B1 (en) * 2004-11-08 2013-05-29 Baxter International Inc. Particulate compositions of tubulin inhibitor
AU2007325797B2 (en) * 2006-11-28 2014-03-13 Ziopharm Oncology, Inc. Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
US10434077B2 (en) 2014-03-31 2019-10-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Glycolic acid and/or D-lactic acid for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
AT374682B (de) 1984-05-25
YU112381A (en) 1985-03-20
IE51285B1 (en) 1986-11-26
DE3119510A1 (de) 1982-02-25
IT1170970B (it) 1987-06-03
GR75658B (sv) 1984-08-02
FI811474L (fi) 1981-11-17
FI70793C (fi) 1986-10-27
NL8102362A (nl) 1981-12-16
FR2482458B1 (sv) 1984-12-14
FI70793B (fi) 1986-07-18
BE888832A (fr) 1981-11-16
DK216681A (da) 1981-11-17
JPH0136445B2 (sv) 1989-07-31
AU7029181A (en) 1981-11-19
SE460457B (sv) 1989-10-16
IT8148467A0 (it) 1981-05-14
ZA813188B (en) 1982-05-26
CA1160571A (en) 1984-01-17
AU543726B2 (en) 1985-05-02
DK159376C (da) 1991-03-25
JPS579716A (en) 1982-01-19
US4360523A (en) 1982-11-23
YU44831B (en) 1991-04-30
ATA221181A (de) 1983-10-15
CH647677A5 (de) 1985-02-15
NZ196985A (en) 1983-06-17
FR2482458A1 (fr) 1981-11-20
GB2076288A (en) 1981-12-02
DK159376B (da) 1990-10-08
LU83363A1 (fr) 1982-01-20
IE811092L (en) 1981-11-16
IT8148467A1 (it) 1982-11-14
DE3119510C2 (sv) 1991-03-07
GB2076288B (en) 1983-12-14

Similar Documents

Publication Publication Date Title
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES507394A0 (es) Mejoras en el objeto de la patente de invencion n.487.721 por procedimiento de preparacion de nuevos derivados del nortropano.
IL63122A (en) Antihistaminic tricyclic alkylcarbamic and sulfamic acid esters,their preparation and pharmaceutical compositions containing them
ES2052629T3 (es) Pirazolo(3,4-d)piridinas, procedimiento para su preparacion y utilizacion como medicamentos.
SE8402550D0 (sv) N-substituerade deriavat av moranolin
SE8103071L (sv) Antitumorkompositioner samt sett att framstella dessa
IL65137A (en) (hetero)aroylimidazolones and pharmaceutical compositions containing them
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
SE8303696D0 (sv) Farmakologiska kompositioner
IE822519L (en) Phosphonic acid derivatives
SE8002831L (sv) Oxitetracyklinberedningar
ES2014438B3 (es) Derivados del acido 2-fosfonobutano-1,2,4tricarboxilico, como agentes emulsivos.
DK578887D0 (da) Antihypertensiva
ATE15602T1 (de) Antitumor-zusammensetzungen.
FI883956A0 (fi) Haorfaergningsaemne.
AU578335B2 (en) N-substituted aziridine-2-carboxylic acid derivatives
BG104452A (en) New derivatives of the methylenebisphosphonic acid
IL44081A0 (en) O-aryl-thionoalkanephosphonic acid ester-imide derivatives, their preparation and their use as insecticides,acaricides or nematocides
IE781283L (en) Sulphonamide-containing pharmaceutical composition
FR2381786A1 (fr) Nouveaux aryl-hexafuranosides, leur preparation et leur application en tant que medicaments
OA05269A (fr) Nouveaux dérivés phosporés, leur préparation et les compositions qui les contiennent.
FR2391217A1 (fr) Derives de l'acide clavulanique, utilisables comme medicament
CH537951A (de) Verfahren zur Herstellung von (+)-(cis-1,2-Epoxypropyl)-phosphonsäure und ihrer Derivate

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8103071-0

Effective date: 19911209

Format of ref document f/p: F